[1] |
Beam E, Osmon D. Prosthetic joint infection update[J]. Infect Dis Clin North Am, 2018, 32(4): 843-859.
|
[2] |
徐一宏,徐卫东. 保留假体清创术治疗假体周围感染疗效的影响因素[J/CD]. 中华关节外科杂志(电子版), 2018, 12(3): 405-410.
|
[3] |
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785.
|
[4] |
Dobson PF, Reed MR. Prevention of infection in primary THA and TKA[J]. EFORT Open Rev, 2020, 5(10): 604-613.
|
[5] |
Thaler M, Lechner R, Dammerer D, et al. The direct anterior approach: treating periprosthetic joint infection of the hip using two-stage revision arthroplasty[J]. Arch Orthop Trauma Surg, 2020, 140(2): 255-262.
|
[6] |
vanden Kieboom J, Tirumala V, Box H, et al. One-stage revision is as effective as two-stage revision for chronic culture-negative periprosthetic joint infection after total hip and knee arthroplasty[J]. Bone Joint J, 2021, 103-B(3): 515-521.
|
[7] |
林丽能,王辉,孙效棠,等. 一期和二期髋关节翻修术后感染复发率的Meta分析[J/CD]. 中华关节外科杂志(电子版), 2019, 13(1): 73-77.
|
[8] |
Zahar A, Gehrke TA. One-stage revision for infected total hip arthroplasty[J]. Orthop Clin North Am, 2016, 47(1): 11-18.
|
[9] |
He JW, Wang J, Cao L, et al. Serum and synovial vancomycin concentrations in patients with prosthetic joint infection after intra-articular infusion[J]. Eur J Drug Metab Pharmacokinet, 2021, 46(5): 637-643.
|
[10] |
Barrett RJ, Sandquist L, Richards BF, et al. Antibiotic-impregnated polymethylmethacrylate as an anterior biomechanical device for the treatment of cervical discitis and vertebral osteomyelitis: technical report of two cases[J]. Turk Neurosurg, 2014, 24(4): 613-617.
|
[11] |
Risitano S, Sabatini L, Atzori F, et al. Static antibiotic spacers augmented by calcium sulphate impregnated beads in revision TKA: surgical technique and review of literature[J]. J Orthop, 2018, 15(2): 313-318.
|
[12] |
Cooper JJ, Florance H, McKinnon JL, et al. Elution profiles of tobramycin and vancomycin from high-purity calcium sulphate beads incubated in a range of simulated body fluids[J]. J Biomater Appl, 2016, 31(3): 357-365.
|
[13] |
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society[J]. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
|
[14] |
Howlin RP, Brayford MJ, Webb JS, et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections[J]. Antimicrob Agents Chemother, 2015, 59(1): 111-120.
|
[15] |
Abosala A, Ali M. The Use of Calcium Sulphate beads in periprosthetic joint infection, a systematic review[J]. J Bone Jt Infect, 2020, 5(1): 43-49.
|
[16] |
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation [J]. J Bone Joint Surg Am, 1969, 51(4): 737-55.
|
[17] |
Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components[J]. Clin Orthop Relat Res, 1990(257): 107-128.
|
[18] |
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America[J/OL]. Clin Infect Dis, 2013, 56(1): e1-e25. DOI: 10.1093/cid/cis803.
|
[19] |
Pivec R, Issa K, Given K, et al. A prospective, longitudinal study of patient satisfaction following total knee arthroplasty using the Short-Form 36 (SF-36) survey stratified by various demographic and comorbid factors[J]. J Arthroplasty, 2015, 30(3): 374-378.
|
[20] |
何斌,章淼锋,沈跃,等. 人工髋关节置换术后初次翻修的原因分析及翻修术疗效评估[J]. 中华骨科杂志,2019, 39(15): 909-917.
|
[21] |
Gristina AG, Costerton JW. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection[J]. Orthop Clin North Am, 1984, 15(3): 517-535.
|
[22] |
Akgün D, Perka C, Trampuz A, et al. Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study[J]. Arch Orthop Trauma Surg, 2018, 138(5): 635-642.
|
[23] |
Bjarnsholt T, Ciofu O, Molin S, et al. Applying insights from biofilm biology to drug development- can a new approach be developed?[J]. Nat Rev Drug Discov, 2013, 12(10): 791-808.
|
[24] |
Lee YK, Lee KH, Nho JH, et al. Retaining well-fixed cementless stem in the treatment of infected hip arthroplasty[J]. Acta Orthop, 2013, 84(3): 260-264.
|
[25] |
Chen KH, Tsai SW, Wu PK, et al. Partial component-retained two-stage reconstruction for chronic infection after uncemented total hip arthroplasty: results of sixteen cases after five years of follow-up[J]. Int Orthop, 2017, 41(12): 2479-2486.
|
[26] |
El-Husseiny M, Haddad FS. The role of highly selective implant retention in the infected hip arthroplasty[J]. Clin Orthop Relat Res, 2016, 474(10): 2157-2163.
|
[27] |
纪保超,李国庆,张晓岗,等. 保留部分假体的一期翻修术治疗全髋关节置换术后慢性感染[J]. 中华骨科杂志,2019, 39(15): 918-925.
|
[28] |
Roberts R, McConoughey SJ, Calhoun JH. Size and composition of synthetic calcium sulfate beads influence dissolution and elution rates in vitro[J]. J Biomed Mater Res B Appl Biomater, 2014, 102(4): 667-673.
|
[29] |
Kilgus DJ, Howe DJ, Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria[J]. Clin Orthop Relat Res, 2002(404): 116-124.
|
[30] |
Lim SJ, Park JC, Moon YW, et al. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol[J]. J Arthroplasty, 2009, 24(8): 1264-1269.
|
[31] |
Karlsen ØE, Borgen P, Bragnes B, et al. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial[J/OL]. J Orthop Surg Res, 2020, 15(1): 365. DOI: 10.1186/s13018-020-01877-2.
|
[32] |
Miller R, Higuera CA, Wu J, et al. Periprosthetic joint infection[J/OL]. JBJS Rev, 2020, 8(7): e19.00224. DOI: 10.2106/jbjs.rvw.19.00224.
|